Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box PubMed
Articles in PubMed by Author:
  arrow  Possick, S. E.
space
  arrow  Barry, M.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REVIEW

SERIES IN PRIMARY CARE INTERNAL MEDICINE

Evaluation and Management of the Cardiovascular Patient Embarking on Air Travel

right arrow Stephen E. Possick, MD, and Michèle Barry, MD

20 July 2004 | Volume 141 Issue 2 | Pages 148-154

Almost 2 billion passengers embark on international and domestic air travel each year. An increasing number of travelers will have cardiovascular disease as the population continues to age and our ability to treat cardiac disease improves. Guidelines for safe air travel in this population vary and are supported by few concrete data from randomized trials. Although the overall risk for clinically significant myocardial ischemia and arrhythmia during flight seems to be low in the population with stable cardiovascular disease, certain groups may be at increased risk. In-flight venous thrombosis is an increasingly recognized potential complication of prolonged air travel. Travelers with cardiovascular disease may be at increased risk for venous thrombosis as a result of depressed ejection fraction or immobility.

This case-based review describes the risks of air travel in a 65-year-old man with known cardiovascular disease. After reviewing the limited data on safe air travel after myocardial infarction and the common complications after both percutaneous intervention and coronary artery bypass grafting, we provide recommendations on safe air travel after myocardial infarction. We discuss the safety of both preflight screening and the in-flight environment with regard to pacemakers and implantable automatic defibrillators. We also review the literature on in-flight venous thrombosis and provide recommendations to prevent in-flight deep venous thrombosis.

Author and Article Information
space

From Yale University School of Medicine, New Haven, Connecticut.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Michèle Barry, MD, Office of International Health, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520-8025; e-mail, michele.barry{at}yale.edu.

Current Author Addresses: Dr. Possick: Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, 333 Cedar Street, FMP3, PO Box 208017, New Haven, CT 06520-8017.

Dr. Barry: Office of International Health, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520-8025.




This article has been cited by other articles:


Home page
Eur Respir JHome page
R. K. Coker, R. J. Shiner, and M. R. Partridge
Is air travel safe for those with lung disease?
Eur. Respir. J., December 1, 2007; 30(6): 1057 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Air Travel by Heart Patients
Journal Watch Cardiology, September 17, 2004; 2004(917): 4 - 4.
[Full Text]




 Home | Current Issue | Past Issues | Audio/Video | CME | Collections | In the Clinic | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2004 by the American College of Physicians.